| Trait Information | |
| Identifier | MONDO_0005627 |
| Description | A primary or metastatic malignant neoplasm affecting the head and neck. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma. [NCIT: C4013] | Trait category |
Other trait
|
| Synonyms |
22 synonyms
|
| Child trait(s) | 6 child traits |
| Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
|---|---|---|---|---|---|---|
| PGS000081 (CC_Oral) |
PGP000050 | Graff RE et al. Nat Commun (2021) |
Oral cavity and pharyngeal cancers | oral cavity cancer, pharynx cancer |
14 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000081/ScoringFiles/PGS000081.txt.gz |
| PGS000617 (PRSWEB_PHECODE190_20001-1030_PRS-CS_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Ocular cancer | ocular cancer | 834,009 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000617/ScoringFiles/PGS000617.txt.gz | |
| PGS000792 (CC_Oral_IV) |
PGP000186 | Kachuri L et al. Nat Commun (2020) |
Oral cavity and pharyngeal cancers | oral cavity cancer, pharynx cancer |
14 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000792/ScoringFiles/PGS000792.txt.gz |
| PGS003390 (best_HNSC) |
PGP000413 | Namba S et al. Cancer Res (2022) |
Head and neck squamous cell carcinoma | head and neck squamous cell carcinoma | 931,477 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003390/ScoringFiles/PGS003390.txt.gz |
| PGS012586 (PRS_HNC_all) |
PGP000822 | Lee YC et al. BMC Med (2024) |
Head and neck squamous cell carcinoma | head and neck squamous cell carcinoma | 972,182 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS012586/ScoringFiles/PGS012586.txt.gz |
| PGS012588 (PRS_HNC_OPC) |
PGP000822 | Lee YC et al. BMC Med (2024) |
Oropharynx cancer | oropharynx cancer | 972,182 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS012588/ScoringFiles/PGS012588.txt.gz |
| PGS018460 (TPMI_145.2_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 11 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018460/ScoringFiles/PGS018460.txt.gz | |
| PGS018461 (TPMI_145.2_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 34,059 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018461/ScoringFiles/PGS018461.txt.gz | |
| PGS018462 (TPMI_145.2_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 570,182 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018462/ScoringFiles/PGS018462.txt.gz | |
| PGS018463 (TPMI_145.2_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 983,776 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018463/ScoringFiles/PGS018463.txt.gz | |
| PGS018464 (TPMI_145.2_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 1,003,968 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018464/ScoringFiles/PGS018464.txt.gz | |
| PGS018470 (TPMI_149.2_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of nasopharynx | malignant tumor of nasopharynx | 211 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018470/ScoringFiles/PGS018470.txt.gz | |
| PGS018471 (TPMI_149.2_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of nasopharynx | malignant tumor of nasopharynx | 45,670 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018471/ScoringFiles/PGS018471.txt.gz | |
| PGS018472 (TPMI_149.2_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of nasopharynx | malignant tumor of nasopharynx | 10,449 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018472/ScoringFiles/PGS018472.txt.gz | |
| PGS018473 (TPMI_149.2_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of nasopharynx | malignant tumor of nasopharynx | 983,776 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018473/ScoringFiles/PGS018473.txt.gz | |
| PGS018474 (TPMI_149.2_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of nasopharynx | malignant tumor of nasopharynx | 1,005,312 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018474/ScoringFiles/PGS018474.txt.gz |
|
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|---|
| PPM000201 | PGS000081 (CC_Oral) |
PSS000120| European Ancestry| 411,577 individuals |
PGP000050 | Graff RE et al. Nat Commun (2021) |
Reported Trait: Oral cavity and pharyngeal cancers | OR: 1.08 [1.02, 1.14] | — | — | Genotyping reagent kit (GERA cohort only), genotyping array (UK Biobank only), age, sex, 10 PCs. | Results from meta-analysis of GERA and UKB |
| PPM002047 | PGS000081 (CC_Oral) |
PSS001020| European Ancestry| 391,479 individuals |
PGP000186 | Kachuri L et al. Nat Commun (2020) |Ext. |
Reported Trait: Incident oral cavity and pharyngeal cancer | HR: 1.11 [1.01, 1.21] | AUROC: 0.702 C-index: 0.686 (0.015) |
— | Age at assessment, sex, genotyping array, PCs(1-15), weekly alcohol intake, cigarettes per day, years of smoking, smoing status (never vs. former vs. current) | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. |
| PPM017173 | PGS000081 (CC_Oral) |
PSS010150| European Ancestry| 415 individuals |
PGP000443 | Byrne S et al. Int J Epidemiol (2023) |Ext. |
Reported Trait: Oral cavity and pharyngeal cancers | HR: 1.03 [0.94, 1.14] | — | — | age at baseline, sex (where relevant), assessment centre, 40 principal components of ancestries (PCs), Townsend Index, education, birth location, income, lifestyle index, additional cancer-specific covariates | — |
| PPM001302 | PGS000617 (PRSWEB_PHECODE190_20001-1030_PRS-CS_MGI_20200608) |
PSS000556| European Ancestry| 672 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of eye | OR: 1.339 [1.033, 1.736] β: 0.292 (0.132) |
AUROC: 0.586 [0.508, 0.658] | Nagelkerke's Pseudo-R²: 0.0152 Brier score: 0.0831 Odds Ratio (OR, top 1% vs. Rest): 4.74 [1.2, 18.7] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE190_20001-1030_PRS-CS_MGI_20200608 |
| PPM002063 | PGS000792 (CC_Oral_IV) |
PSS001020| European Ancestry| 391,479 individuals |
PGP000186 | Kachuri L et al. Nat Commun (2020) |
Reported Trait: Incident oral cavity and pharyngeal cancer | HR: 1.12 [1.02, 1.23] | AUROC: 0.702 C-index: 0.687 (0.015) |
R²: 0.356 | Age at assessment, sex, genotyping array, PCs(1-15), weekly alcohol intake, cigarettes per day, years of smoking, smoing status (never vs. former vs. current) | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. |
| PPM016265 | PGS003390 (best_HNSC) |
PSS010079| European Ancestry| 270,233 individuals |
PGP000413 | Namba S et al. Cancer Res (2022) |
Reported Trait: head and neck squamous cell carcinoma | — | AUROC: 0.672 | R²: 0.00561 | age, sex, top 20 genetic principal components | — |
| PPM030758 | PGS012586 (PRS_HNC_all) |
PSS012280| Multi-ancestry (including European)| 38,401 individuals |
PGP000822 | Lee YC et al. BMC Med (2024) |
Reported Trait: Head and neck squamous cell carcinoma | OR: 1.17 [1.07, 1.26] | — | — | age, sex, ethnicity, and PC 1 to 10 | — |
| PPM030759 | PGS012586 (PRS_HNC_all) |
PSS012280| Multi-ancestry (including European)| 38,401 individuals |
PGP000822 | Lee YC et al. BMC Med (2024) |
Reported Trait: Oral cavity cancer | OR: 1.14 [1.06, 1.23] | — | — | age, sex, ethnicity, and PC 1 to 10 | — |
| PPM030753 | PGS012586 (PRS_HNC_all) |
PSS012281| European Ancestry| 308,492 individuals |
PGP000822 | Lee YC et al. BMC Med (2024) |
Reported Trait: Head and neck squamous cell carcinoma | OR: 1.12 [1.06, 1.17] | — | — | age, sex, genotype array, and PC 1 to 10 | — |
| PPM030754 | PGS012586 (PRS_HNC_all) |
PSS012281| European Ancestry| 308,492 individuals |
PGP000822 | Lee YC et al. BMC Med (2024) |
Reported Trait: Oral cavity cancer | OR: 1.1 [1.02, 1.17] | — | — | age, sex, genotype array, and PC 1 to 10 | — |
| PPM030755 | PGS012586 (PRS_HNC_all) |
PSS012281| European Ancestry| 308,492 individuals |
PGP000822 | Lee YC et al. BMC Med (2024) |
Reported Trait: Oropharynx cancer | OR: 1.18 [1.08, 1.28] | — | — | age, sex, genotype array, and PC 1 to 10 | — |
| PPM030760 | PGS012586 (PRS_HNC_all) |
PSS012280| Multi-ancestry (including European)| 38,401 individuals |
PGP000822 | Lee YC et al. BMC Med (2024) |
Reported Trait: Oropharynx cancer | OR: 1.13 [1.05, 1.22] | — | — | age, sex, ethnicity, and PC 1 to 10 | — |
| PPM030761 | PGS012588 (PRS_HNC_OPC) |
PSS012283| Multi-ancestry (including European)| 37,901 individuals |
PGP000822 | Lee YC et al. BMC Med (2024) |
Reported Trait: Oropharynx cancer | OR: 1.24 [1.08, 1.42] | — | — | age, sex, ethnicity, and PC 1 to 10 | — |
| PPM030757 | PGS012588 (PRS_HNC_OPC) |
PSS012284| European Ancestry| 307,295 individuals |
PGP000822 | Lee YC et al. BMC Med (2024) |
Reported Trait: Oropharynx cancer | OR: 1.09 [1.02, 1.17] | — | — | age, sex, genotype array, and PC 1 to 10 | — |
| PPM036642 | PGS018460 (TPMI_145.2_Lassosum2) |
PSS012358| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68616 | R²: 0.01171 | sex, age, array, PCs 1-10 | — |
| PPM036643 | PGS018461 (TPMI_145.2_LDpred2) |
PSS012357| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68599 | R²: 0.01168 | sex, age, array, PCs 1-10 | — |
| PPM036644 | PGS018462 (TPMI_145.2_MegaPRS) |
PSS012359| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68604 | R²: 0.0117 | sex, age, array, PCs 1-10 | — |
| PPM036645 | PGS018463 (TPMI_145.2_PRS-CS) |
PSS012360| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68622 | R²: 0.0117 | sex, age, array, PCs 1-10 | — |
| PPM036646 | PGS018464 (TPMI_145.2_SBayesR) |
PSS012361| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68563 | R²: 0.01173 | sex, age, array, PCs 1-10 | — |
| PPM036652 | PGS018470 (TPMI_149.2_Lassosum2) |
PSS012368| East Asian Ancestry| 19,070 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of nasopharynx | — | AUROC: 0.7073 | R²: 0.01637 | sex, age, array, PCs 1-10 | — |
| PPM036653 | PGS018471 (TPMI_149.2_LDpred2) |
PSS012367| East Asian Ancestry| 19,070 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of nasopharynx | — | AUROC: 0.71186 | R²: 0.01717 | sex, age, array, PCs 1-10 | — |
| PPM036654 | PGS018472 (TPMI_149.2_MegaPRS) |
PSS012369| East Asian Ancestry| 19,070 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of nasopharynx | — | AUROC: 0.69527 | R²: 0.01463 | sex, age, array, PCs 1-10 | — |
| PPM036655 | PGS018473 (TPMI_149.2_PRS-CS) |
PSS012370| East Asian Ancestry| 19,070 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of nasopharynx | — | AUROC: 0.70955 | R²: 0.0161 | sex, age, array, PCs 1-10 | — |
| PPM036656 | PGS018474 (TPMI_149.2_SBayesR) |
PSS012371| East Asian Ancestry| 19,070 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of nasopharynx | — | AUROC: 0.69866 | R²: 0.01489 | sex, age, array, PCs 1-10 | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS000120 | Cancer diagnoses were obtained from reigstry data in GERA, and ICD-9/10 codes mapped to ICD-O-3 codes in UK Biobank. Cancers for this phenotype were classified using the following SEER site recode(s): 20010, 20020, 20030, 20040, 20050, 20060, 20070, 20080, 20090, and 20100 | — | [ ,
46.0 % Male samples |
Mean = 58.0 years | European | — | GERA, UKB | — |
| PSS000556 | PheCode:190; ICD9CM:190.0, 190.1, 190.2, 190.3, 190.4, 190.5, 190.6, 190.7, 190.8, 190.9, 234.0, V10.84; ICD10CM:C69, C69.0, C69.00, C69.01, C69.02, C69.1, C69.10, C69.11, C69.12, C69.2, C69.20, C69.21, C69.22, C69.3, C69.30, C69.31, C69.32, C69.4, C69.40, C69.41, C69.42, C69.5, C69.50, C69.51, C69.52, C69.6, C69.60, C69.61, C69.62, C69.8, C69.80, C69.81, C69.82, C69.9, C69.90, C69.91, C69.92, D09.2, D09.20, D09.21, D09.22 | — | [
|
— | European | — | MGI | — |
| PSS012280 | — | — | [
|
— | European | — | PMB | — |
| PSS012280 | — | — | [
|
— | African American or Afro-Caribbean | — | PMB | — |
| PSS012281 | — | — | [ ,
45.5 % Male samples |
Mean = 58.0 years Sd = 7.9 years |
European | — | UKB | — |
| PSS012283 | — | — | [
|
— | European, African American or Afro-Caribbean | — | PMB | — |
| PSS012284 | — | — | [
|
— | European | — | UKB | — |
| PSS012357 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012358 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012359 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012360 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012361 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS010079 | C01-06, C09, C10, C13, C14 | — | [
|
— | European (British) |
— | UKB | Controls were samples without any cancer diagnosis or self-reported cancer |
| PSS012367 | 147,C11 | — | [ ,
45.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012368 | 147,C11 | — | [ ,
45.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012369 | 147,C11 | — | [ ,
45.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012370 | 147,C11 | — | [ ,
45.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012371 | 147,C11 | — | [ ,
45.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS010150 | — | — | [
|
— | European | — | UKB | — |
| PSS001020 | Individuals with at least one recorded incident diagnosis of a borderline, in situ, or malignant primary cancer were defined as cases. | — | [
|
— | European | — | UKB | — |